Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | yes | yes: 2 |
Forrest at al. (procyclic) | yes | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4I0E9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 203 | 205 | PF00675 | 0.460 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.538 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 203 | 205 | PF00082 | 0.459 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.522 |
CLV_PCSK_SKI1_1 | 15 | 19 | PF00082 | 0.560 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.619 |
DEG_APCC_DBOX_1 | 148 | 156 | PF00400 | 0.423 |
DEG_APCC_DBOX_1 | 28 | 36 | PF00400 | 0.463 |
DOC_MAPK_gen_1 | 191 | 200 | PF00069 | 0.622 |
DOC_MAPK_gen_1 | 203 | 211 | PF00069 | 0.406 |
DOC_MAPK_MEF2A_6 | 179 | 186 | PF00069 | 0.554 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.483 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.327 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.618 |
DOC_USP7_UBL2_3 | 11 | 15 | PF12436 | 0.554 |
DOC_USP7_UBL2_3 | 125 | 129 | PF12436 | 0.483 |
DOC_USP7_UBL2_3 | 133 | 137 | PF12436 | 0.492 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.482 |
DOC_USP7_UBL2_3 | 158 | 162 | PF12436 | 0.424 |
DOC_USP7_UBL2_3 | 171 | 175 | PF12436 | 0.508 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.801 |
LIG_14-3-3_CanoR_1 | 203 | 209 | PF00244 | 0.564 |
LIG_14-3-3_CanoR_1 | 213 | 223 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 67 | 73 | PF00244 | 0.523 |
LIG_14-3-3_CanoR_1 | 92 | 99 | PF00244 | 0.730 |
LIG_Actin_WH2_2 | 110 | 127 | PF00022 | 0.534 |
LIG_APCC_Cbox_2 | 73 | 79 | PF00515 | 0.595 |
LIG_BRCT_BRCA1_1 | 95 | 99 | PF00533 | 0.632 |
LIG_Dynein_DLC8_1 | 201 | 207 | PF01221 | 0.394 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.449 |
LIG_FHA_1 | 203 | 209 | PF00498 | 0.568 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.600 |
LIG_FHA_2 | 68 | 74 | PF00498 | 0.583 |
LIG_LIR_Gen_1 | 196 | 201 | PF02991 | 0.624 |
LIG_LIR_Gen_1 | 220 | 230 | PF02991 | 0.580 |
LIG_LIR_Nem_3 | 103 | 109 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.565 |
LIG_LIR_Nem_3 | 220 | 226 | PF02991 | 0.525 |
LIG_SH2_NCK_1 | 24 | 28 | PF00017 | 0.494 |
LIG_SH2_STAP1 | 172 | 176 | PF00017 | 0.553 |
LIG_SH2_STAP1 | 24 | 28 | PF00017 | 0.481 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.455 |
LIG_SUMO_SIM_par_1 | 59 | 66 | PF11976 | 0.427 |
LIG_UBA3_1 | 127 | 133 | PF00899 | 0.467 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.571 |
MOD_CK1_1 | 224 | 230 | PF00069 | 0.570 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.614 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.617 |
MOD_CK2_1 | 164 | 170 | PF00069 | 0.506 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.531 |
MOD_CK2_1 | 50 | 56 | PF00069 | 0.557 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.507 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.475 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.724 |
MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.792 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.701 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.533 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.600 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.550 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.705 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.580 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.614 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.684 |
MOD_PIKK_1 | 202 | 208 | PF00454 | 0.522 |
MOD_PIKK_1 | 50 | 56 | PF00454 | 0.605 |
MOD_PKA_1 | 147 | 153 | PF00069 | 0.562 |
MOD_PKA_1 | 15 | 21 | PF00069 | 0.509 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.546 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.510 |
MOD_PKA_2 | 91 | 97 | PF00069 | 0.685 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.529 |
MOD_Plk_2-3 | 151 | 157 | PF00069 | 0.508 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.498 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.784 |
MOD_SUMO_rev_2 | 118 | 127 | PF00179 | 0.537 |
MOD_SUMO_rev_2 | 150 | 160 | PF00179 | 0.595 |
MOD_SUMO_rev_2 | 4 | 13 | PF00179 | 0.676 |
TRG_DiLeu_BaEn_1 | 196 | 201 | PF01217 | 0.575 |
TRG_DiLeu_BaEn_1 | 9 | 14 | PF01217 | 0.591 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.573 |
TRG_Pf-PMV_PEXEL_1 | 191 | 196 | PF00026 | 0.502 |
TRG_Pf-PMV_PEXEL_1 | 50 | 54 | PF00026 | 0.550 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCG3 | Leptomonas seymouri | 48% | 99% |
A0A1X0NYD1 | Trypanosomatidae | 28% | 90% |
A0A3Q8ICK8 | Leishmania donovani | 100% | 100% |
A0A3R7KGK2 | Trypanosoma rangeli | 25% | 100% |
A4HCW9 | Leishmania braziliensis | 59% | 100% |
E9AWB2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |
Q4QB63 | Leishmania major | 90% | 100% |